TY  - GEN
AU  - Lehtinen,Matti
AU  - Paavonen,Jorma
AU  - Wheeler,Cosette M
AU  - Jaisamrarn,Unnop
AU  - Garland,Suzanne M
AU  - Castellsagué,Xavier
AU  - Skinner,S Rachel
AU  - Apter,Dan
AU  - Naud,Paulo
AU  - Salmerón,Jorge
AU  - Chow,Song-Nan
AU  - Kitchener,Henry
AU  - Teixeira,Júlio C
AU  - Hedrick,James
AU  - Limson,Genara
AU  - Szarewski,Anne
AU  - Romanowski,Barbara
AU  - Aoki,Fred Y
AU  - Schwarz,Tino F
AU  - Poppe,Willy A J
AU  - De Carvalho,Newton S
AU  - Germar,Maria Julieta V
AU  - Peters,Klaus
AU  - Mindel,Adrian
AU  - De Sutter,Philippe
AU  - Bosch,F Xavier
AU  - David,Marie-Pierre
AU  - Descamps,Dominique
AU  - Struyf,Frank
AU  - Dubin,Gary
TI  - Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
SN  - 1474-5488
PY  - 2012///0221
KW  - Adenocarcinoma
KW  - diagnosis
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Adolescent
KW  - Adult
KW  - Age Factors
KW  - Aluminum Hydroxide
KW  - Asia
KW  - Australia
KW  - DNA, Viral
KW  - analysis
KW  - Double-Blind Method
KW  - Europe
KW  - Female
KW  - Human papillomavirus 16
KW  - genetics
KW  - Human papillomavirus 18
KW  - Humans
KW  - Lipid A
KW  - Neoplasm Grading
KW  - North America
KW  - Papillomavirus Infections
KW  - Papillomavirus Vaccines
KW  - South America
KW  - Time Factors
KW  - Treatment Outcome
KW  - Uterine Cervical Neoplasms
KW  - Young Adult
KW  - Uterine Cervical Dysplasia
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(11)70286-8
ER  -